Abstract: Loma salmonae (Microsporea) is a serious gill pathogen of seawater pen-reared chinook salmon Oncorhynchus tshawytscha. Fumagillin DCH has been used to control other microsporean and myxosporean diseases of fishes, and the efficacy of this drug for controlling L. salmonae infections was investigated. Chinook salmon were experimentally infected with L. salmonae in seawater tanks. At 1 wk post initial exposure, 2 tanks of 12 fish each were fed Fumagillin DCH in the diet at 10 mg drug kg-' fish d-' for 30 d, and 2 other tanks of exposed fish were maintained as non-treated controls. None of the surviving 22 Fumagillin-treated fish exhibited L. salmonae infections when examined at 44 d post initial exposure, while 13 of 21 untreated fish were infected. This preliminary study suggests that Fumagillin DCH may be a useful therapeutant for controlling L. salmonae infections. 1981 , 1983 , Hauck 1984 , Magor 1987 . Although most reports of L. salmonae have been from fishes in fresh water, infections can persist after fish are transferred to seawater (Wood 1974) . In addition, the parasite can be transmitted in seawater (Kent et al. 1995). In seawater netpens, severe gill lesions associated with the infection have been observed in coho salmon Oncorhynchus kisutch (Kent et al. 1989 , Speare et al. 1989 ) and chinook salmon Oncorhynchus tshawytscha (Kent 1992). Chemotherapeutants are not routinely used for treating microsporean infections in fish; however, Fumagillin DCH may be a good candidate for this purpose. Fumagillin DCH is an antimicrobial agent used primarily for treating Nosema apis (Microsporea) infections in honey bees. The drug apparently acts by inhibiting RNA synthesis (Jaronski 1972). Kano et al. (1982) reported that Fumagillin DCH was effective against the microsporean Pleistophora anguillarum in eels Anguilla japonica and the drug has been used to control Enterocytozoon salmonis infections in chinook salmon (Hedrick et al. 1991) . There have also been reports on successful treatment of various myxosporean diseases of fishes, including those affecting salmonids (Molnar et al. 1987 , Hedrick et al. 1988 , Szekely et al. 1988 , Wishkovsky et al. 1990 , Yokoyama et al. 1990 , El-Matbouli & Hoffmann 1991 , SitjaBobadilla & Alvarez-Pellitero 1992.
Loma salmonae (Putz, Hoffman & Dunbar, 1965) (Microsporea) infects the gills and other vascularized tissues of wild and hatchery-reared salmonids in fresh water throughout the Pacific Northwest of North America (Wales & Wolf 1955 , Putz et al. 1965 , Putz & McLaughlin 1970 , Morrison & Sprague 1981 , 1983 , Hauck 1984 , Magor 1987 . Although most reports of L. salmonae have been from fishes in fresh water, infections can persist after fish are transferred to seawater (Wood 1974) . In addition, the parasite can be transmitted in seawater (Kent et al. 1995) . In seawater netpens, severe gill lesions associated with the infection have been observed in coho salmon Oncorhynchus kisutch (Kent et al. 1989 , Speare et al. 1989 ) and chinook salmon Oncorhynchus tshawytscha (Kent 1992 ). Chemotherapeutants are not routinely used for treating microsporean infections in fish; however, Fumagillin DCH may be a good candidate for this purpose. Fumagillin DCH is an antimicrobial agent used primarily for treating Nosema apis (Microsporea) infections in honey bees. The drug apparently acts by inhibiting RNA synthesis (Jaronski 1972). Kano et al. (1982) reported that Fumagillin DCH was effective against the microsporean Pleistophora anguillarum in eels Anguilla japonica and the drug has been used to control Enterocytozoon salmonis infections in chinook salmon (Hedrick et al. 1991) . There have also been reports on successful treatment of various myxosporean diseases of fishes, including those affecting salmonids (Molnar et al. 1987 , Hedrick et al. 1988 , Szekely et al. 1988 , Wishkovsky et al. 1990 , Yokoyama et al. 1990 , El-Matbouli & Hoffmann 1991 , SitjaBobadilla & Alvarez-Pellitero 1992 .
Based on these reports, about 3 to 10 mg Fumagillin kg-' fish d-' is the recommended dose for treating salmonids. Higher concentrations or prolonged treatment (e.g. 30 to 60 d) may cause toxic side effects (Lauren et al. 1989 , Wishkovsky et al. 1990 ). The drug is not heat stable. Therefore, it is recommended that the feed be coated with the drug, instead of incorporated in the feed during milling. The following laboratory study was conducted to determine if Fumagillin DCH is a potential candidate drug for the control of Loma salmonae infections in chinook salmon.
Materials and methods. A total of 48 chinook salmon (average weight 22 g) were divided into 4 groups of 12 fish each and were placed in 14 l tanks with running seawater at 15OC. The fish were reared on dechlorinated tap water before the experiment and previous examination demonstrated that the stock was free of Loma salmonae. Fish in each tank were exposed to L. salmonae as follows. Approximately 5 g of chinook salmon gill tissue containing numerous L. salmonae xenomas (collected from a commercial netpen site) were placed in sterile saline, chopped finely and introduced to the aquarium. The water flow to each tank was turned off for 2 h to enhance contact of the parasite with the fish. Fish were exposed by this method 3 times on alternating days at the beginning of the experiments. We have successfully used this method for experimentally infecting fish with L. salmonae in another study (Kent et al. 1995) .
Fish in 2 of the 4 tanks were treated with Fumagillin DCH in the feed at 10 mg drug kg-' fish d -' for 30 d, starting 1 wk after initial exposure to Loma salmonae. Fumagillin DCH is 60 to 70% active, and thus the fish were treated with 6 to 7 mg active drug kg-' fish d-'. Treated feed was prepared by dissolving Fumagillin DCH in 95 % ethanol and spraying commercial pellets with the solution. The concentration of the drug in the feed was 1 g drug kg-' feed, and fish were fed at 1 % body wt d-l. Fish in the 2 other tanks were fed the same diet (at 1 % body wt d-l) that was untreated.
All fish were examined 1 wk after the treatment was completed. Fish were euthanized with an overdose of MS-222 (tricaine methanesulfonate). Four gill arches were collected from each fish and preserved in Davidson's solution. Histological sections were prepared from each arch, stained with hematoxylin and eosin, and examined for the presence of Loma salmonae.
Results. Three untreated fish died at 15, 19 and 27 d after initial exposure, and 2 treated fish died on 26 and 41 d after initial exposure. The remaining fish in all tanks were euthanized at 44 d post initial exposure and gills were examined. None of the Fumagillin-treated fish exhibited Loma salmonae infections. Eight of 11 fish from one non-treated tank and 5 of 11 fish in the other non-treated tank were infected with L. salmonae. Numerous xenomas filled with the spores were observed in gill filaments and lamellae in histological sections. The mean weights of the treated fish in each of the 2 tanks were 23.1 + 3.8 g and 23.5 + 6.8 g, and the mean weights in the control (untreated) tanks were 26.1. + 6.8 g and 25.5 + 8.9 g. One-way analysis of variance revealed no significant differences in the weights of fish among tanks (p < 0.05).
Discussion. This study indicates that oral treatment with Fumagillin is an effective method for controlling Loma salmonae infections in salmon, and is the first report on chemical treatment of L. salmonae infections. Various toxic side effects have been reported in salmonids fed high doses of Fumagillin DCH (Hedrick et al. 1988 , Lauren et al. 1989 . Hedrick et al. (1988) reported depletion of hematopoietic cells in the kidney and vacuolation of the renal epithelium in chinook salmon fed Fumagillin DCH at 10 mg drug kg-' fish d -' for 7 wk. MIishkovsky et al. (1990) reported similar changes in rainbow trout Oncorhynchus mykiss fed the drug at 7.5 to 10 or 15 to 20 mg drug k g ' fish d-l for 4 wk, and the spleen and anterior kidney were grossly reduced in size in some of these fish after 8 wk. In another study, rainbow trout fed at 3.75 or 15 mg drug kg-' fish d-l for 60 d also showed degenerative changes in hematopoietic tissue and reduced hematocrit values. Furthermore, prolonged treatment with Fumagillin DCH at high levels (e.g. 15 to 20 mg drug kg-' fish d-l) may cause a reduction in growth in rainbow trout (Wishkovsky et al. 1990 ). In our study, no toxic side effects attributable to the Fumagillin treatment were observed, and mortality and final average weights were similar in both groups. However, our study was carried out for only 45 d after exposure to the parasite and fish were fed at a reduced level to ensure that all the Furnagillin-treated feed was eaten.
Although results from this preliminary study are encouraging, further research is needed to determine the precise treatment regime for controlling Loma salmonae (and other microsporean and myxosporean infections) in salmon without inducing significant toxic side effects. The fish were treated shortly after experimental L. salmonae infection, and it is unknown if the drug would be efficacious if applied during advanced infections in which xenomas are either fully formed or in a state of degeneration.
